What is the clinical significance of stromal angiogenesis in Barrett's esophagus?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 2, 2008, Pages

  Moriyama, Nobuyuki ^a   Amano, Yuji ^b   Mishima, Yuko ^a   Okita, Koichi ^a   Takahashi, Yoshiko ^a   Yuki, Takafumi ^a   Ishimura, Norihisa ^a   Ishihara, Shunji ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiogenesis; Barrett's esophagus; Hypoxia inducible factor 1 expression

Indexed keywords

CD34 ANTIGEN; CYCLINE; CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; BARRETT ESOPHAGUS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG USE; ESOPHAGUS BIOPSY; FEMALE; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS; SCORING SYSTEM; STROMA; STRUCTURED QUESTIONNAIRE;

EID: 57449112762     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05440.x     Document Type: Conference Paper

References (38)

1. Blot WJ, Devesa SS, Kneller RW, Flaumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991 265 : 1287 9.
2. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zingmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993 104 : 510 3.
3. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83 : 2049 53.
4. Amano Y, Ishihara S, Kushiyama Y et al. Barrett's esophagus with predominant intestinal metaplasia correlates with superficial COX-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by NSAIDs usage. Aliment. Pharmacol. Ther. 2004 20 : 793 802.
5. Amano Y, Kushiyama Y, Yuki T et al. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand. J. Gastroenterol. 2006 41 : 873 9.
6. Amano Y, Chinuki D, Yuki T et al. Efficacy of proton pump inhibitors for cellular proliferation and apoptosis in Barrett's oesophagus with different mucin phenotypes. Aliment. Pharmacol. Ther. 2006 24 (Suppl. 4 41 8.
7. Chinuki D, Amano Y, Ishihara S et al. REG Ia protein expression in Barrett's esophagus. J. Gastroenterol. Hepatol. 2008 23 : 296 302.
8. Harrison RF, Perry I, Jankowski JA. Barrett's mucosa: remodeling by the microenvironment. J. Pathol. 2000 192 : 1 3.
9. Couvelard A, Paraf F, Gratio V et al. Angiogenesis in the neoplastic sequence of Barrett's oesophagus: correlation with VEGF expression. J. Pathol. 2000 192 : 14 8.
10. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992 12 : 5447 54.
11. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 2002 277 : 38205 11.
12. Fukuda R, Kelly B, Semenza GL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 2003 63 : 2330 4.
13. Zhong H, Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor-1a in common human cancers and their metastases. Cancer Res. 1999 59 : 5830 5.
14. Baatar D, Jones MK, Tsugawa K et al. Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing. Am. J. Pathol. 2002 161 : 1449 57.
15. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 1998 33 : 1023 9.
16. Armstrong D. Towards consistency in the endoscopic diagnosis of Barrett's oesophagitis and columnar metaplasia (Review article). Aliment. Pharmacol. Ther. 2004 20 (Suppl. 5 40 7.
17. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006 131 : 1392 9.
18. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus: the Practice Parameter Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 1998 93 : 1028 32.
19. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004 127 : 310 30.
20. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 45 : 172 80.
21. Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J. Gastroenterol. Hepatol. 2001 16 : 132 6.
22. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969 3 : 87 97.
23. Amano Y, Kushiyama Y, Ishihara S et al. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short segment Barrett's esophagus. Am. J. Gastroenterol. 2005 100 : 21 6.
24. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 1991 324 : 1 8.
25. Yuki T, Amano Y, Takahashi Y et al. A case report of mucosal Barrett's cancer with vessel involvement, with special reference to indications for endoscopic mucosal resection. Esophagus 2006 3 : 19 22.
26. Möbius C, Stein HJ, Becker I et al. The 'angiogenic switch' in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Eur. J. Surg. Oncol. 2003 29 : 890 4.
27. Auvinen MI, Sihvo EI, Ruohtula T et al. Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma. J. Clin. Oncol. 2002 20 : 2971 9.
28. Willam C, Warnecke C, Schefold JC et al. Inconsistent effects of acidosis on HIF-1a protein and its target genes. Pflügers Arch. 2006 451 : 534 43.
29. Lord RV, Park JM, Wickramasinghe K et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J. Thorac. Cardiovasc. Surg. 2003 125 : 246 53.
30. Piazuelo E, Jimenez P, Lanas A. COX-2 inhibition in esophagitis, Barrett's esophagus and esophageal cancer. Curr. Pharm. Des. 2003 9 : 2267 80.
31. Sihvo EI, Salminen JT, Rantanen TK et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int. J. Cancer 2002 102 : 551 5.
32. Sihvo EI, Ruohtula T, Auvinen MI, Koivistoinen A, Harjula AL, Salo JA. Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus. J. Thorac. Cardiovasc. Surg. 2003 126 : 1952 7.
33. Hermann B, Li Y, Ray MB, Wo JM, Martin RC 2nd. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Arch. Surg. 2005 140 : 1204 9.
34. Wilson KT. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus. Dis. Esophagus 2002 15 : 16 21.
35. Möbius C, Stein HJ, Spiess C et al. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur. J. Surg. Oncol. 2005 31 : 755 9.
36. von Rahden BH, Stein HJ, Puhringer F et al. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res. 2005 65 : 5038 44.
37. Amano Y, Kushiyama Y, Yuki T et al. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy. J. Gastroenterol. Hepatol. 2007 22 : 901 7.
38. waf-1, p27, and PCNA in Barrett's esophagus. J. Cell. Physiol. 2006 207 : 512 19.